Unknown

Dataset Information

0

Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.


ABSTRACT: Complement activation is involved in the pathogenesis of ischemia reperfusion injury (IRI), which is an inevitable process during kidney transplantation. Therefore, complement-targeted therapeutics hold great potential in protecting the allografts from IRI. We observed universal deposition of C3d and membrane attack complex in human renal allografts with delayed graft function or biopsy-proved rejection, which confirmed the involvement of complement in IRI. Using FB-, C3-, C4-, C5-, C5aR1-, C5aR2-, and C6-deficient mice, we found that all components, except C5aR2 deficiency, significantly alleviated renal IRI to varying degrees. These gene deficiencies reduced local (deposition of C3d and membrane attack complex) and systemic (serum levels of C3a and C5a) complement activation, attenuated pathological damage, suppressed apoptosis, and restored the levels of multiple local cytokines (e.g., reduced IL-1?, IL-9, and IL-12p40 and increased IL-4, IL-5, IL-10, and IL-13) in various gene-deficient mice, which resulted in the eventual recovery of renal function. In addition, we demonstrated that CRIg/FH, which is a targeted complement inhibitor for the classical and primarily alternative pathways, exerted a robust renoprotective effect that was comparable to gene deficiency using similar mechanisms. Further, we revealed that PI3K/AKT activation, predominantly in glomeruli that was remarkably inhibited by IRI, played an essential role in the CRIg/FH renoprotective effect. The specific PI3K antagonist duvelisib almost completely abrogated AKT phosphorylation, thus abolishing the renoprotective role of CRIg/FH. Our findings suggested that complement activation at multiple stages induced renal IRI, and CRIg/FH and/or PI3K/AKT agonists may hold the potential in ameliorating renal IRI.

SUBMITTER: Hu C 

PROVIDER: S-EPMC6287101 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.

Hu Chao C   Li Long L   Ding Peipei P   Li Ling L   Ge Xiaowen X   Zheng Long L   Wang Xuanchuan X   Wang Jina J   Zhang Weitao W   Wang Na N   Gu Hongyu H   Zhong Fan F   Xu Ming M   Rong Ruiming R   Zhu Tongyu T   Hu Weiguo W  

Journal of immunology (Baltimore, Md. : 1950) 20181114 12


Complement activation is involved in the pathogenesis of ischemia reperfusion injury (IRI), which is an inevitable process during kidney transplantation. Therefore, complement-targeted therapeutics hold great potential in protecting the allografts from IRI. We observed universal deposition of C3d and membrane attack complex in human renal allografts with delayed graft function or biopsy-proved rejection, which confirmed the involvement of complement in IRI. Using <i>FB</i>-, <i>C3</i>-, <i>C4</i  ...[more]

Similar Datasets

| S-EPMC9132383 | biostudies-literature
| S-EPMC8825366 | biostudies-literature
2012-08-10 | GSE39766 | GEO
| S-EPMC6503883 | biostudies-literature
| S-EPMC6933315 | biostudies-literature
| S-EPMC4818254 | biostudies-literature
| S-EPMC9010483 | biostudies-literature
| S-EPMC8568755 | biostudies-literature
| S-EPMC10051224 | biostudies-literature
| S-EPMC3488944 | biostudies-literature